Galmed Pharmaceuticals Ltd Shares Fall 0.6% Below Previous 52-Week Low - Market Mover
The shares fell 0.6% lower than its previous 52-week low of $1.76, with trading volume higher than its 30 day average
Dec 30, 2021 by Kwhen Finance Editors
Galmed Pharmaceuticals Ltd (GLMD) shares closed 0.6% lower than its previous 52 week low, giving the company a market cap of $45M. The stock is currently down 41.8% year-to-date, down 44.1% over the past 12 months, and down 50.7% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%.
Trading Activity
- Trading volume this week was 244.1% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Galmed Pharmaceuticals Ltd | -3.3 | -41.8 | -44.1 | -71.4 | 1.7 |
| Dow Jones Industrial Average | 0.2 | 21.0 | 21.8 | -0.3 | 23.9 |
| S&P 500 Index | 0.1 | 29.2 | 29.8 | -0.4 | 32.5 |
| Health Care | 0.6 | 23.0 | 24.6 | -0.8 | 26.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 12.7%
- The company's stock price performance over the past 12 months lags the peer average by 24.3%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Galmed Pharmaceuticals Ltd | GLMD | 0 | -41.8 | -44.1 | -71.4 | 1.7 |
| Peer Avg | N/A | 12.8 | -37.1 | -35.5 | -57.4 | 36.4 |
| Catalent Inc. | CTLT | 39.4 | 20.5 | 21.9 | -12.0 | 28.3 |
| Endo International plc | ENDP | 13.7 | -44.3 | -36.9 | -63.1 | 107.2 |
| Aerie Pharmaceuticals Inc | AERI | -2.1 | -46.1 | -48.2 | -66.2 | 1.1 |
| Evoke Pharma Inc | EVOK | 0 | -78.4 | -78.7 | -88.5 | 8.8 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: